- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07943208
Gluteus Maximus Transfer for Hip Abductor Insufficiency Following Total Hip Arthroplasty
Clinical and Functional Outcomes of Gluteus Maximus Transfer for the Management of Hip Abductor Insufficiency Following Total Hip Arthroplasty: A Clinical Study
Hip abductor insufficiency is a challenging complication following total hip arthroplasty (THA). It may result from damage to the abductor muscles or tendons, particularly the gluteus medius and minimus, and can lead to persistent hip pain, muscle weakness, a positive Trendelenburg sign, and impaired walking ability.
Gluteus maximus transfer is a surgical procedure used to restore the function of the hip abductor mechanism in patients with severe abductor insufficiency. This study aims to evaluate the clinical and functional outcomes of gluteus maximus transfer in patients who develop abductor insufficiency following total hip arthroplasty.
The study will assess postoperative improvements in hip function, abductor strength, gait, pain, and patient-reported functional outcomes, as well as the occurrence of postoperative complications. The hypothesis is that gluteus maximus transfer can provide meaningful functional improvement in appropriately selected patients with persistent abductor insufficiency following total hip arthroplasty.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
**Inclusion Criteria**
- Adult patients aged 18 years or older.
- Patients who underwent primary or revision total hip arthroplasty.
- Patients with symptomatic hip abductor insufficiency following total hip arthroplasty.
- Clinical evidence of abductor mechanism deficiency, including abductor weakness, positive Trendelenburg sign, or gait disturbance.
- Patients with irreparable or functionally deficient hip abductor mechanism considered suitable for gluteus maximus transfer.
- Availability of preoperative and postoperative clinical and functional assessment data.
**Exclusion Criteria**
- Active periprosthetic joint infection at the time of the planned procedure.
- Neurological disorders significantly affecting hip abductor function or gait.
- Severe gluteus maximus muscle dysfunction or insufficiency that precludes transfer.
- Severe medical comorbidities contraindicating surgery.
- Inadequate clinical follow-up or missing essential outcome data.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Gluteus Maximus Transfer
Patients with hip abductor insufficiency following total hip arthroplasty undergoing gluteus maximus transfer for reconstruction of the deficient hip abductor mechanism. |
Surgical transfer of the gluteus maximus muscle to reconstruct the deficient hip abductor mechanism in patients with persistent abductor insufficiency following total hip arthroplasty. The procedure aims to improve hip abductor function, pelvic stability, gait, and overall functional outcomes. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Hip Abductor Muscle Strength
Délai: Preoperative assessment and 12 months postoperatively.
|
Assessment of hip abductor muscle strength before and after gluteus maximus transfer using manual muscle testing according to the Medical Research Council (MRC) grading scale (0-5). |
Preoperative assessment and 12 months postoperatively.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Functional Outcome - Harris Hip Score
Délai: preoperative baseline to 12 months postoperatively
|
Change in Harris Hip Score from preoperative baseline to 12 months postoperatively to assess hip pain and function. |
preoperative baseline to 12 months postoperatively
|
|
Trendelenburg Sign
Délai: preoperative and 12 month postoperative
|
Assessment of the presence or absence of Trendelenburg sign during clinical examination before and 12 month after surgery. |
preoperative and 12 month postoperative
|
|
Pain Assessment
Délai: preoperative and 12 months postoperative
|
Change in hip pain intensity measured using the Visual Analog Scale (VAS). |
preoperative and 12 months postoperative
|
|
Postoperative Complications
Délai: during the period of follow up 12 months postoperative
|
Documentation of postoperative complications, including persistent abductor weakness, infection, dislocation, wound complications, and revision surgery. |
during the period of follow up 12 months postoperative
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- asy453789
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .